Log In
BCIQ
Print this Print this
 

CAR-T CD19, CBM-C19.1

  Manage Alerts
Collapse Summary General Information
Company Cellular Biomedicine Group Inc.
DescriptionT cells expressing a chimeric antigen receptor (CAR) specific to the CD19 antigen
Molecular Target CD19
Mechanism of Action 
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today